Catenin-beta (Phospho-Thr41/Ser45) antibody
如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: Catenin-beta (Phospho-Thr41/Ser45) antibody
產(chǎn)品型號(hào):
產(chǎn)品展商: immunoclone
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
Catenin-beta (Phospho-Thr41/Ser45) antibody迅速增長(zhǎng)的產(chǎn)品線包括一抗、二抗、**測(cè)定及細(xì)胞檢測(cè)試劑盒、蛋白/多肽、激動(dòng)劑/拮抗劑/活化劑/抑制劑及裂解物等。Catenin-beta (Phospho-Thr41/Ser45) antibody嚴(yán)格的質(zhì)量控制和驗(yàn)證實(shí)驗(yàn)包括各種不同的應(yīng)用：WB、細(xì)胞**熒光、**組化、流式細(xì)胞術(shù)、ELISA、CHIP、IP和peptide array。
Catenin-beta (Phospho-Thr41/Ser45) antibody
的詳細(xì)介紹
Catenin-beta (Phospho-Thr41/Ser45) antibodyProduct Profile
|
Product Name
|
Rabbit anti-Catenin-beta (Phospho-Thr41/Ser45) polyclonal antibody
|
|
Antibody Type
|
Primary Antibodies
|
|
Immunogen
|
The antiserum was produced against synthesized peptide derived from human Catenin-beta around the phosphorylation site of Thr41/Ser45.
|
Catenin-beta (Phospho-Thr41/Ser45) antibodyKey Feature
|
Clonality
|
Polyclonal
|
|
Host Species
|
Rabbit
|
|
Tested Applications
|
WBELISA
|
|
|
WB:1:500~1:1000
ELISA:1:20000
|
|
Species Reactivity
|
HumanMouseRat
|
|
Concentration
|
1 mg/ml
|
|
Purification
|
Affinity purified
|
Catenin-beta (Phospho-Thr41/Ser45) antibodyTarget Information
|
Gene Symbol
|
CTNNB1
|
|
Gene Synonyms
|
Catenin beta-1
Beta-catenin
CTNNB1
CTNNB
OK/SW-cl.35
PRO2286
More
|
Catenin-beta (Phospho-Thr41/Ser45) antibodyDatabase Links
|
Entrez Gene
|
1499
|
|
Unigene
|
476018
|
|
OMIM
|
116806
132600
155255
|
|
SwissProt ID
|
P35222
|
Catenin-beta (Phospho-Thr41/Ser45) antibodyApplication
-
Western blot
Western blot analysis of extracts from HepG2 cells, using Catenin-beta (Phospho-Thr41/Ser45) Antibody. The lane on the right is treated with the synthesized peptide
|
Application Notes
|
WB:1:500~1:1000
ELISA:1:20000
|
Additional Information
|
Form
|
Liquid
|
|
Storage Instructions
|
store at -20°C. Avoid repeated freeze / thaw cycles
|
|
Storage Buffer
|
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
|
